Beth A. Tarini, M.D., MS, conducts health services research that focuses on optimizing the delivery of genetic services to families and children, particularly newborn screening. Dr. Tarini's research has been funded by the National Institutes of Health, HRSA, the Robert Wood Johnson Foundation and the Cystic Fibrosis Foundation. She has served as chairwoman of the Michigan NBS Quality Assurance Advisory Committee and chairwoman-elect of the Iowa Congenital and Inherited Disorders Advisory Committee, both of which make newborn screening policy recommendations to state legislatures.
She currently serves as a member of the Advisory Committee on Heritable Disorders in Newborns and Children, a committee which advises the Secretary of the U.S. Department of Health and Human Services on the most appropriate application of universal newborn screening tests, technologies, policies, guidelines and standards. In May 2019, Dr. Tarini became vice president of the Society for Pediatric Research, a four-year leadership term that includes serving as president for one year.